Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Technology Scientific & Technical Instruments
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > New Press Release - Ventripoint Updates Submission to U.S. Food and Drug Administration for its Next Generation, AI-powered Heart-scanning Technology
View:
Comment by G1945V on Jan 23, 2025 4:48am
I received a dear friend email from George Adams which stated the following: "1. VMS+4.0 is the next generation product which has a number of features to make it more user friendly and provide automated analysis using conventional AI to select the anatomical landmarks in the heart.  It really is a breakthrough product as automated analysis has been a goal for the entire industry for ...more  
Comment by jopatclo on Jan 23, 2025 7:45am
Interesting & see on post Ventripoint yesterday and see see like this Dr.Gregory James Skinner & Dario Freitas -Gregory James Skinner Hors rseau·Consultant Paediatric Cardiologist and Deputy Clinical Director - Women & Children’s Services -Dario Freitas Lead Clinical Scientist for the ACHD Echocardiography service | Guy's and St Thomas' NHS Foundation Trust  ...more  
VentriPoint Diagnostics Ltd